CD24 expression in ovarian cancer has been found to correlate with clinicopathological parameters, such as higher tumor grade, higher tumor stage, omental metastasis, relapse, and a more aggressive course of the disease [17,66,79]. The gene discussed is CD24; the disease is neoplasm.